...
首页> 外文期刊>The American Journal of the Medical Sciences >Urinary neutrophil gelatinase-associated lipocalin: A potential biomarker for predicting rapid progression of drug-induced chronic tubulointerstitial nephritis.
【24h】

Urinary neutrophil gelatinase-associated lipocalin: A potential biomarker for predicting rapid progression of drug-induced chronic tubulointerstitial nephritis.

机译:尿中性粒细胞明胶酶相关的脂钙素:一种潜在的生物标志物,可预测药物引起的慢性肾小管间质性肾炎的快速发展。

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: The role of urinary biomarkers of kidney injury in the prediction of adverse clinical outcomes in drug-induced chronic tubulointerstitial nephritis (D-CTIN) has not been well described. Methods: A total of 36 patients with D-CTIN were enrolled in the study. The baseline urinary excretion of neutrophil gelatinase-associated lipocalin (NGAL), alpha1-microglobin (alpha1-MG), albumin (mAlb) and total protein were measured, and estimated glomerular filtration rate change rates within a period of 6 to 33 (mean: 24 months) follow-up months were recorded. Results: Areas under the receiver-operator characteristic curve of urinary NGAL, alpha1-MG, mAlb and total protein for predicting deterioration of estimated glomerular filtration rate were 0.707, 0.631, 0.685 and 0.678, respectively. The cutoff points that maximized the combined sensitivity and specificity for NGAL, alpha1-MG, mAlb and total protein were 37.71 ng/mL, 33.20 microg/mL, 6.91 mg/L and 60.00 mg/L, respectively. At these thresholds, the sensitivity and specificity was 64.7% and 78.9% for NGAL, 66.7% and 50.0% for alpha1-MG, 80.0% and 50.0% for mAlb and 70.6% and 63.2% for total protein, respectively. The median renal survival time (years) of patients with urinary NGAL level exceeding 37.705 ng/mL was shorter than that of patients with urinary NGAL level below 37.705 ng/mL (1.59 +/- 0.79 versus 2.09 +/- 0.63, P = 0.040, chi(2) = 4.218). Conclusions: Increase of baseline urinary NGAL was better than alpha1-MG, mAlb and total protein in predicting renal function deterioration in patients with D-CTIN. This noninvasive approach has potential to serve as a practical tool in D-CTIN prognosis.
机译:简介:肾损伤的尿液生物标志物在药物诱导的慢性肾小管间质性肾炎(D-CTIN)不良临床结局的预测中的作用尚未得到很好的描述。方法:共有36名D-CTIN患者入选本研究。测量中性粒细胞明胶酶相关脂钙蛋白(NGAL),α1-微球蛋白(alpha1-MG),白蛋白(mAlb)和总蛋白的基线尿排泄量,并估计6至33天内的肾小球滤过率变化率(平均值:记录了24个月的随访时间。结果:用于预测肾小球滤过率恶化的尿NGAL,α1-MG,mAlb和总蛋白的接收者-操作者特征曲线下的面积分别为0.707、0.631、0.685和0.678。使NGAL,α1-MG,mAlb和总蛋白的组合敏感性和特异性最大化的临界点分别为37.71 ng / mL,33.20 microg / mL,6.91 mg / L和60.00 mg / L。在这些阈值下,NGAL的敏感性和特异性分别为64.7%和78.9%,α1-MG为66.7%和50.0%,mAlb为80.0%和50.0%,总蛋白为70.6%和63.2%。尿NGAL水平超过37.705 ng / mL的患者的肾脏中位生存时间(年)比尿NGAL水平低于37.705 ng / mL的患者的中位肾脏生存时间短(1.59 +/- 0.79对2.09 +/- 0.63,P = 0.040 ,chi(2)= 4.218)。结论:在预测D-CTIN患者肾功能恶化时,基线尿NGAL的增加优于alpha1-MG,mAlb和总蛋白。这种非侵入性方法有潜力作为D-CTIN预后的实用工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号